AMGN

Amgen Inc.NASDAQ · StockSectorHealthcare IndustryBiotechnologyExchangeNASDAQ

$468.15+3.12 (+0.67%)US pre-market · opens in 4h 16m

At close

Free account:WatchlistPrice and earnings alertsTrade TalkNo trading account needed

Daily move+0.7%vs prev close $465.03

VolatilityModerateATR $11.46 · 2.4%

Gap %−0.9%Open vs prev close

52-week position92%of range $312.53–$482.50

Loading chart…

Why is AMGN moving?

Automated summary · updated 04:00 ET

AMGN is up 0.7% as of the last close. We found no company-specific news; that’s within its normal daily range.

NoteWithin its normal range

Built automatically from market data. Not investment advice.

Part of

Collections that include AMGN

ThemeWeight-loss drugs+2.0% today

IndustryBiotechnology0.0% today

SectorHealthcare+0.8% today

Index compositeNasdaq-100 components+1.4% today

Index compositeS&P 500 components+1.2% today

ExchangeNASDAQ-listed+2.5% today

Investor holdings

Held by 9 of 50 tracked investors13F · Q3 2026 · filed by Nov 16

6added3trimmed

Fisher Asset ManagementKen Fisher · Asset manager0.2%$713MAdded +6%D. E. ShawDavid E. Shaw · Quant fund0.3%$467MAdded +625%Two Sigma InvestmentsJohn Overdeck & David Siegel · Quant fund0.3%$409MAdded +1475%Citadel AdvisorsKen Griffin · Multi-strategy fund0.1%$255MAdded +281%AQR Capital ManagementCliff Asness · Quant fund0.0%$108MAdded +97%US long positions only · filings lag the quarter end by up to 45 days · SEC EDGAR 13F · All tracked investors

Key stats

Stock

Open / Prev close: $460.94 / $465.03
Day range: $459.25 – $468.21
52-week range: $312.53 – $482.50
Volume: 69.1K
Market cap: $171B
ATR (14): $11.46 · 2.4% · Moderate
Gap %: −0.9%
Industry today: Biotechnology 0.0%

SEC filings

All filings

Nov 9, 2026Insider trade reportedInsider trade · SEC EDGARForm 4 Nov 9, 2026Insider trade reportedInsider trade · SEC EDGARForm 4 Nov 3, 2026Quarterly report filedQuarterly report · SEC EDGAR10-Q Nov 3, 2026Reported results of operationsMaterial event · SEC EDGAR8-K Oct 26, 2026Director or officer changeMaterial event · SEC EDGAR8-K Aug 4, 2026Quarterly report filedQuarterly report · SEC EDGAR10-Q

About Amgen

Amgen Inc. is listed on NASDAQ and belongs to the Biotechnology industry in the Healthcare sector.

Sector: Healthcare
Industry: Biotechnology
Market cap: $171B
Exchange: NASDAQ

AMGN FAQ

When is AMGN’s next earnings report?

Feb 1, 2027, after the close. Analysts expect EPS of $5.71.

Why is AMGN stock moving today?

AMGN is up 0.7% as of the last close.

How volatile is AMGN?

AMGN’s average true range over 14 days is $11.46, 2.4% of its price. That puts it in our moderate volatility class.

Best match for stocks

Put your AMGN edge to the test with Trade The Pool

Stock-specific funded accounts. Trade US equities like AMGN with firm capital and keep a share of the profits.